RT info:eu-repo/semantics/article T1 Impact of the rotavirus vaccine in Valladolid, Spain: An interrupted time series analysis A1 Pérez Rubio, Alberto A1 Luquero Alcalde, Francisco Javier A1 Bachiller Luque, María Rosario A1 Torre Pardo, Paz de la A1 Eiros Bouza, José María K1 Rotavirus K1 Vaccine K1 32 Ciencias Médicas AB Rotavirus vaccines (RV) have decreased the infant morbidity and mortality in countries that included RVin their national schedule. Rotavirus vaccination is recommended by the Spanish Society of Pediatrics;however, Spain, as most countries in Europe, has authorized commercialization but not included RV inits national vaccination program. We assessed the impact of RV on the rotavirus hospitalization ratethrough an interrupted time series analysis. There was a 46.8% (95% CI: 29.3–60.2) decrease on the rotavirushospitalizations rate in the study region after RV commercialization in 2006. Currently there is limitedevidence about the impact of RV in Europe, especially among countries not offering systematicvaccination in their national schedule. Documentation of RV coverage, effectiveness and impact isurgently needed in these countries. PB Elsevier SN 1879-4378 YR 2016 FD 2016 LK http://uvadoc.uva.es/handle/10324/45301 UL http://uvadoc.uva.es/handle/10324/45301 LA eng NO Trials in Vaccinology, 2016, vol. 5, p. 84-87 NO Producción Científica DS UVaDOC RD 28-mar-2024